Some hormone therapy patches are still in short supply. Here’s what experts recommend to avoid missing a dose. By Danielle Friedman When Ellen Winn was in her late 40s, she began having night sweats ...
Hosted on MSN
ASTRO: 30 percent with ER+ early-stage breast cancer remain on endocrine therapy at five years
MONDAY, Oct. 5, 2026 (HealthDay News) -- Less than 30 percent of women with estrogen receptor (ER)-positive early-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results